Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2019-01-02 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于转让浙江赛尚医药科技有限公司67%股权的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the progress of a share transfer transaction involving Zhejiang Saishang Pharmaceutical Technology Co., Ltd. It details the history of the share transfer agreement, payment delays, legal actions, mediation outcomes, and future payment obligations. The content focuses on the update of a capital transaction and related legal proceedings rather than a full financial report or earnings release. The document length is short (1284 characters) and it is an announcement of progress on a financing-related matter, not a full report or detailed financial data. Therefore, it fits best under Capital/Financing Update (CAP).
2019-01-02 Chinese
关于2019年第一次临时股东大会通知的更正公告
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a correction announcement regarding the notice for the 2019 first extraordinary general meeting (临时股东大会) of shareholders. It details corrections to the meeting agenda and voting matters, including the date, voting system, and agenda items. It does not contain actual financial statements or results, nor is it a full report. It is an announcement related to shareholder meeting logistics and agenda corrections. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly a Regulatory Filing (RNS). However, since it is a correction to a shareholder meeting notice and involves voting agenda items, it aligns best with Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on meeting corrections, not the meeting results themselves, but given the content about voting agenda corrections, DVA is the closest fit.
2018-12-28 Chinese
关于召开2019年第一次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2019 first extraordinary general meeting (临时股东大会) of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed, voting procedures, attendance requirements, and proxy authorization forms. The document does not contain financial statements or results but serves as a notice to shareholders about the meeting and how to participate and vote. It is not a report of the meeting results or a proxy solicitation but a preparatory announcement for the meeting itself. Given the content and length (3208 characters), it fits the category of a formal meeting notice or announcement. The closest matching filing category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. Although this is an extraordinary meeting, the category AGM-R is the best fit for shareholder meeting notices and related materials. Confidence is high due to the clear meeting notice nature and detailed voting instructions.
2018-12-28 Chinese
2019年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as the "2019 First Extraordinary General Meeting (EGM)" of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It contains detailed meeting materials including the agenda, voting procedures, and specific proposals to be voted on by shareholders. The content includes the announcement of the meeting, the rules for the meeting, and the text of the proposals to amend the company bylaws and extend the validity of fundraising resolutions. The document is a presentation of materials for a shareholders meeting rather than a report of voting results or a summary of the meeting outcome. It is not a full annual or interim report, nor is it a transcript or earnings release. The document is a set of meeting materials provided to shareholders for the EGM, which fits the definition of AGM Information (AGM-R), as it is the equivalent for an extraordinary meeting and includes presentations and materials shared during the meeting.
2018-12-24 Chinese
关于控股股东及一致行动人增持公司股份计划的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the progress of a shareholding increase plan by the controlling shareholder and its concerted parties. It details the number of shares increased, the percentage of total shares, and the timeline of the share purchase plan. There is no financial report, earnings data, or management discussion. The content focuses on shareholding changes by major shareholders, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and it is not an announcement of a report publication or a certification. Therefore, the correct classification is MRQ with high confidence.
2018-12-21 Chinese
关于收到行政监管措施决定书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding receipt of administrative regulatory measures from the China Securities Regulatory Commission (CSRC) Tianjin Bureau. It details regulatory actions including a warning letter and supervisory talks related to the company's failure to timely fulfill shareholder meeting procedures and disclosure obligations concerning a significant asset transfer. The document does not contain financial statements or detailed financial data but rather reports on regulatory enforcement actions and compliance issues. It is not a full annual or interim report, audit report, or earnings release. It is also not a simple announcement of a report publication but a regulatory filing about administrative measures. Therefore, the document fits best under Regulatory Filings (RNS).
2018-12-20 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.